INO

Rosen Law Firm has filed a class action lawsuit against Inovio Pharmaceuticals, Inc. (NASDAQ: INO). Investors who purchased securities between October 10, 2023 and December 26, 2025 can seek to lead the class by April 7, 2026. The lawsuit alleges securities fraud.

AI-generated: summaries written by AI from the linked sources. How we use AI